Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00412269 · ClinicalTrials.gov registry record
Healthy Transitions: Menopause Effect on Obesity, Energy Balance, and Insulin
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 160
- Enrollment target
NCT00412269: Completed study, sponsored by Pennington Biomedical Research Center.
NCT00412269 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 160 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00412269 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 160 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of menopause on obesity, energy balance, and insulin in postmenopausal, obese women.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 1998-02 |
| Est. Completion | 2007-03 |
What the finished NCT00412269 record still lists
NCT00412269 is an observational study that tracks outcomes without assigning an intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00412269 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00412269 about?
NCT00412269 is a clinical study titled "Healthy Transitions: Menopause Effect on Obesity, Energy Balance, and Insulin". The purpose of this study is to determine the effect of menopause on obesity, energy balance, and insulin in postmenopausal, obese women.
What is the current status of trial NCT00412269?
This trial is currently completed. The enrollment target is 160 participants. The study started on 1998-02. Estimated completion is 2007-03.
Who is sponsoring clinical trial NCT00412269?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia